Skip to main content

Want a detailed portfolio tracker?

Burning Rock Biotech (BNR) P/E (2020 - 2026)

Burning Rock Biotech (BNR) P/E from Jun 12, 2020 to Jul 21, 2026. The TTM Burning Rock Biotech (BNR) P/E is -0.97. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Burning Rock Biotech (BNR)

YearP/EChange
2026-0.97-53.10%
2025-2.08+198.52%
2024-0.70-27.42%
2023-0.96-58.67%
2022-2.32-76.39%
2021-9.82-58.74%
2020-23.80N/A

Comparison Burning Rock Biotech (BNR) P/E with competitors

Burning Rock Biotech (BNR) P/E is -0.97.

TickerNameP/EUpside
ADVBAdvanced Biomed Inc1.05-207.67%
MBAICheckCap Ltd1.71-275.88%
FONRFonar Corp15.48-1689.46%
QGENQiagen NV20.03-2156.87%
DGXQuest Diagnostics Inc22.47-2407.79%
LHLaboratory Corp Of America Holdings23.87-2551.33%
IQVIQVIA Holdings Inc25.28-2696.30%
AAgilent Technologies Inc26.96-2868.33%
TMOThermo Fisher Scientific Inc31.53-3337.71%
MTDMettler-Toledo International Inc32.45-3432.34%
MEDPMedpace Holdings Inc32.55-3442.56%
DHRDanaher Corp38.55-4059.05%
IDXXIdexx Laboratories Inc40.58-4266.68%
ILMNIllumina Inc44.12-4630.65%
RVTYRevvity Inc52.68-5509.82%
VCYTVeracyte Inc53.71-5615.67%
ICLRIcon Plc57.45-5999.68%
SHCSotera Health Company74.08-7707.74%
WATWaters Corp102.79-10655.10%